The Childhood Cancer Blog
The Childhood Cancer Blog
DIPG is a rare but lethal tumor that occurs in the brainstem. It mixes cancer cells with normal cells. About 300-400 children are diagnosed each year and live an average of 10 months after diagnosis.
Michelle Monje, pictured here at her lab at Stanford University. In addition to DIPG research, Dr. Monje also studies spinal cord tumors, which can share genetic characteristics similar to high-grade gliomas like DIPG. Dr. Monje is also the co-chair for the High-Grade Glioma section at ALSF's Crazy 8 meeting this September in Philadelphia.
Kayne Finley was a kind and compassionate high school senior. In October 2016, Kayne experienced unusual health issues which led to a diagnosis of DIPG. One year and one day later, Kayne passed away. Kayne is pictured above with his mother, brother and father.
For doctors to find cures for lethal brain tumors, they need tissue samples. However, samples from a biopsy are often only enough for a clinician to use to determine the diagnosis. There is typically little left over for research purposes. Families and patients can make profound and meaningful gifts by donating post-mortem tissue to research labs to help doctors replicate, model and study tumors in ways not possible before. In the months before his death, Kayne, pictured above, signed a directive ensuring his tumor could be donated for DIPG research.
by Trish Adkins
When a child receives the diagnosis of diffuse intrinsic pontine glioma (DIPG), the diagnosis comes with an end date.
Thus far, DIPG is always lethal.
But, ALSF-funded grantee Dr. Michelle Monje of Stanford University, does not believe it has to be. Dr. Monje, who specializes in studying high-grade gliomas, is close to a powerful breakthrough that could change the prognosis for children with DIPG.
... Read More
Above, this map shows the RNA clustering of childhood cancer PDX models. RNA works as a messenger inside of cells, carrying instructions from DNA for controlling cellular activities, like cell division.
by Trish Adkins
In 2000, the first draft of the map of human genome—a mosaic representation of characteristics of what makes our biology uniquely human—was released. The map paved the way for more genomics research in several fields ranging from human biology to agriculture and gave scientists models of genetically normal cells which they could compare to abnormal cells, like those cells that make childhood cancer so deadly.
Now, in 2018, an ALSF funded-research project has resulted in the release of over 270 genetic sequences of 25 different types of childhood cancer used... Read More
For childhood cancer researchers, publishing in a scientific journal is not just about the prestige and accomplishment. Publishing is one of the key ways scientists can collaborate and move closer to breakthroughs and cures for children.
“The purpose of research is the generation of new knowledge. If research is kept private and placed in a drawer then it is useless,” said Dr. Adolfo Ferrando of Columbia University, who published his research about a mutation that drives the relapse of acute lymphoblastic... Read More
Pages